Save your place

Sign in to WhoBought

Please try again later.

Coherus BioSciences, Inc. (CHRS) institutional ownership

Latest close $1.41 Jul 24, 2026
Market cap$102M 52-week range SectorHealthcare
Funds holding · Q1 2026
129
reported CHRS position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
83 buyers · 46 sellers

Coherus BioSciences, Inc. (CHRS) price and institutional activity

Dates

Q1 2026

$0 bought by 83 investors
Samsara Biocapital, LLCAlyeska Investment Group, L.P. +81 more
$0 sold by 46 investors
VanguardTang Capital Management LLC +44 more
Bought Sold Totals per quarter; hover a bar for the names.

Coherus BioSciences, Inc. (CHRS) institutional activity · 129

Investor Type Est. change Change Δ Own Date
Samsara Biocapital, LLC · New
Change +3.4M Date Q1 2026
Samsara Biocapital, LLC New· Q1 2026 +3.4M Q1 2026
Vanguard · Reduced
Change −3.0M Date Q1 2026
Vanguard Reduced· Q1 2026 −3.0M Q1 2026
Alyeska Investment Group, L.P. · New
Change +2.2M Date Q1 2026
Alyeska Investment Group, L.P. New· Q1 2026 +2.2M Q1 2026
Two Sigma Investments, LP · Added
Change +1.8M Δ Own +356.9% Date Q1 2026
Two Sigma Investments, LP Added· Q1 2026 +1.8M +356.9% Q1 2026
Propel Bio Management, LLC · New
Change +1.4M Date Q1 2026
Propel Bio Management, LLC New· Q1 2026 +1.4M Q1 2026
Hudson Bay Capital Management LP · Added
Change +870K Date Q1 2026
Hudson Bay Capital Management LP Added· Q1 2026 +870K Q1 2026
Tang Capital Management LLC · Reduced
Change −838K Date Q1 2026
Tang Capital Management LLC Reduced· Q1 2026 −838K Q1 2026
Jane Street Group, LLC · Reduced
Change −563K Date Q1 2026
Jane Street Group, LLC Reduced· Q1 2026 −563K Q1 2026
Goldman Sachs Group Inc · Added
Change +389K Date Q1 2026
Goldman Sachs Group Inc Added· Q1 2026 +389K Q1 2026
Geode · Added
Change +376K Date Q1 2026
Geode Added· Q1 2026 +376K Q1 2026
Millennium Management LLC · Reduced
Change −348K Date Q1 2026
Millennium Management LLC Reduced· Q1 2026 −348K Q1 2026
AQR Capital Management LLC · Added
Change +320K Date Q1 2026
AQR Capital Management LLC Added· Q1 2026 +320K Q1 2026
Informed Momentum Co LLC · New
Change +310K Date Q1 2026
Informed Momentum Co LLC New· Q1 2026 +310K Q1 2026
Two Sigma Advisers, LP · Exited
Change −308K Δ Own −100.0% Date Q1 2026
Two Sigma Advisers, LP Exited· Q1 2026 −308K −100.0% Q1 2026
Simplify Asset Management Inc. · New
Change +253K Date Q1 2026
Simplify Asset Management Inc. New· Q1 2026 +253K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 129

Famous investor activity in Coherus BioSciences, Inc. (CHRS)

Coherus BioSciences, Inc. (CHRS) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Satvat Ali J. · Director 2 operations 90K
Owned 60K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Satvat Ali J. Director 2 operations 90K 60K Jun 5, 2026 Jun 9, 2026
Karachun Rita A. · Director 2 operations 90K
Owned 60K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Karachun Rita A. Director 2 operations 90K 60K Jun 5, 2026 Jun 9, 2026
Newcomer Lee Nisley · Director 2 operations 90K
Owned 60K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Newcomer Lee Nisley Director 2 operations 90K 60K Jun 5, 2026 Jun 9, 2026
Ryan Michael Lee · Director 2 operations 90K
Owned 60K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Ryan Michael Lee Director 2 operations 90K 60K Jun 5, 2026 Jun 9, 2026
O'Donnell-Tormey Jill · Director 2 operations 90K
Owned 60K Trade date Jun 5, 2026 Filed date Jun 9, 2026
O'Donnell-Tormey Jill Director 2 operations 90K 60K Jun 5, 2026 Jun 9, 2026
Wahlstrom Mats · Director 2 operations 90K
Owned 60K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Wahlstrom Mats Director 2 operations 90K 60K Jun 5, 2026 Jun 9, 2026
Newton Charles W. · Director 2 operations 90K
Owned 60K Trade date Jun 5, 2026 Filed date Jun 9, 2026
Newton Charles W. Director 2 operations 90K 60K Jun 5, 2026 Jun 9, 2026
McMichael Bryan J. · CFO 6 operations -220K
Owned 0 Trade date May 29, 2026 Filed date Jun 2, 2026
McMichael Bryan J. CFO 6 operations -220K 0 May 29, 2026 Jun 2, 2026
McMichael Bryan J. · CFO 6 operations 220K
Owned 30K Trade date May 29, 2026 Filed date Jun 2, 2026
McMichael Bryan J. CFO 6 operations 220K 30K May 29, 2026 Jun 2, 2026
Lanfear Dennis M. · Director 9 operations -3.2M
Owned 0 Trade date May 29, 2026 Filed date Jun 2, 2026
Lanfear Dennis M. Director 9 operations -3.2M 0 May 29, 2026 Jun 2, 2026
Lanfear Dennis M. · Director 9 operations 3.2M
Owned 225K Trade date May 29, 2026 Filed date Jun 2, 2026
Lanfear Dennis M. Director 9 operations 3.2M 225K May 29, 2026 Jun 2, 2026
Lanfear Dennis M. · Director, Officer 2 operations 1.1M
Owned 750K Trade date Jan 23, 2026 Filed date Jan 26, 2026
Lanfear Dennis M. Director, Officer 2 operations 1.1M 750K Jan 23, 2026 Jan 26, 2026
McMichael Bryan J. · Officer 2 operations 338K
Owned 225K Trade date Jan 22, 2026 Filed date Jan 26, 2026
McMichael Bryan J. Officer 2 operations 338K 225K Jan 22, 2026 Jan 26, 2026
McMichael Bryan J. · Officer Tax withholding or exercise payment (F) -$3K
Price $1.55 Qty -2K Owned 21K Trade date Jan 20, 2026 Filed date Jan 22, 2026
McMichael Bryan J. Officer Tax withholding or exercise payment (F) $1.55 -2K -$3K 21K Jan 20, 2026 Jan 22, 2026
Lanfear Dennis M. · Director, Officer Tax withholding or exercise payment (F) -$18K
Price $1.55 Qty -12K Owned 673K Trade date Jan 20, 2026 Filed date Jan 22, 2026
Lanfear Dennis M. Director, Officer Tax withholding or exercise payment (F) $1.55 -12K -$18K 673K Jan 20, 2026 Jan 22, 2026
15 of 15

Coherus BioSciences, Inc. (CHRS) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
BlackRock Inc. 12.1M
% of shares outstanding 10.8% Filing date Jan 24, 2024
BlackRock Inc. 12.1M 10.8% Jan 24, 2024
Timothy G. Youngquist 2020 Irrevocable Trust 12.8M
% of shares outstanding 8.3% Filing date May 15, 2026
Timothy G. Youngquist 2020 Irrevocable Trust 12.8M 8.3% May 15, 2026
Alliancebernstein L.P. 6.2M
% of shares outstanding 8.0% Filing date Feb 14, 2023
Alliancebernstein L.P. 6.2M 8.0% Feb 14, 2023
Vanguard Group Inc 5.8M
% of shares outstanding 7.5% Filing date Feb 9, 2023
Vanguard Group Inc 5.8M 7.5% Feb 9, 2023
Citadel Advisors LLC 5.8M
% of shares outstanding 6.1% Filing date May 19, 2023
Citadel Advisors LLC 5.8M 6.1% May 19, 2023
Blackrock, Inc. 7.3M
% of shares outstanding 4.9% Filing date Apr 27, 2026
Blackrock, Inc. 7.3M 4.9% Apr 27, 2026
Temasek Holdings (private) Ltd 5.5M
% of shares outstanding 4.8% Filing date Jul 23, 2024
Temasek Holdings (private) Ltd 5.5M 4.8% Jul 23, 2024
Satterfield Thomas A Jr 6.9M
% of shares outstanding 4.6% Filing date Apr 29, 2026
Satterfield Thomas A Jr 6.9M 4.6% Apr 29, 2026
8 of 16

Coherus BioSciences, Inc. (CHRS) ownership FAQ

Who owns CHRS?

129 reporting institutions disclosed CHRS position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.